+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lutetium-177 Market by Application (Cancer Treatment, Palliative Care, Radiopharmaceutical Therapy), Type (Carrier-Added Lutetium-177, No-Carrier-Added Lutetium-177), End-user, Production, Delivery Form, Developing Technologies - Global Forecast 2025-2030- Product Image
Lutetium-177 Market by Application (Cancer Treatment, Palliative Care, Radiopharmaceutical Therapy), Type (Carrier-Added Lutetium-177, No-Carrier-Added Lutetium-177), End-user, Production, Delivery Form, Developing Technologies - Global Forecast 2025-2030- Product Image
Sale

Lutetium-177 Market by Application (Cancer Treatment, Palliative Care, Radiopharmaceutical Therapy), Type (Carrier-Added Lutetium-177, No-Carrier-Added Lutetium-177), End-user, Production, Delivery Form, Developing Technologies - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • November 2024
  • Region: Global
  • 360iResearch™
  • ID: 5997366
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lutetium-177 Market grew from USD 167.70 million in 2023 to USD 202.56 million in 2024. It is expected to continue growing at a CAGR of 21.44%, reaching USD 653.53 million by 2030.

Lutetium-177 is a radiopharmaceutical isotope used extensively in targeted cancer therapy, particularly for the treatment of neuroendocrine tumors and metastatic prostate cancer. Its unique properties allow precise targeting and minimal impact on surrounding healthy tissues. The necessity for Lutetium-177 is driven by the increasing prevalence of cancer and the need for more effective treatment methods that offer fewer side effects compared to conventional therapies. In terms of application, Lutetium-177's role in theranostics - combining therapeutic and diagnostic capabilities - positions it as a significant player in personalized medicine. End-use sectors predominantly include hospitals, nuclear medicine facilities, and pharmaceutical companies specializing in oncology.

Market growth is influenced by advancements in nuclear medicine, increasing acceptance of radiopharmaceuticals, and supportive regulatory frameworks. Recent developments in biotechnology and precision medicine present potential opportunities for amplifying the adoption of Lutetium-177. To capitalize on these opportunities, stakeholders should focus on enhancing production capabilities and expanding applications to new types of cancers. Partnerships with academic and research institutions can also spur innovation and maximize the potential of Lutetium-177.

Despite its potential, the market faces limitations including high production costs, stringent regulatory requirements, and challenges associated with the handling and transport of radioactive materials. Competition from alternative therapies and the need for specialized infrastructure further impacts market penetration. Areas for innovation include improving isotope production efficiency, developing less costly synthesis processes, and expanding theranostic capabilities. Emphasizing patient-centric approaches and exploring synergies with emerging technologies such as artificial intelligence in diagnostics can drive further advancements.

Overall, the Lutetium-177 market is characterized by its promising growth potential amidst challenges that call for strategic navigation. Collaborative efforts in research and a focus on regulatory compliance will be pivotal in unlocking new avenues and tapping into the compound's full market potential.

Understanding Market Dynamics in the Lutetium-177 Market

The Lutetium-177 Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of cancer globally spurs demand for innovative radiopharmaceutical treatments
    • Increasing investment in research and development accelerates new applications for lutetium-177
    • Growing awareness among healthcare professionals regarding the benefits of lutetium-177 therapies
  • Market Restraints
    • Potential competition from alternative radionuclides and treatments reducing market share for lutetium-177
    • Environmental and waste disposal challenges associated with the production of lutetium-177
    • Challenges in ensuring stringent quality control standards for lutetium-177 radiopharmaceuticals
  • Market Opportunities
    • Identifying unmet needs in Lutetium-177-based treatments during research and development phases
    • Analyzing the rise of Lutetium-177 isotopes in global nuclear medicine markets
    • Evaluating strategic partnerships and collaborations in Lutetium-177 supply chains globally
  • Market Challenges
    • Competition from existing and emerging radionuclide therapies posing a threat to Lutetium-177 market share
    • Addressing the cost constraints linked to the production and distribution of Lutetium-177 therapies
    • Market education and awareness issues impacting the prescription levels of Lutetium-177 treatments by professionals

Exploring Porter’s Five Forces for the Lutetium-177 Market

Porter’s Five Forces framework further strengthens the insights of the Lutetium-177 Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Lutetium-177 Market

External macro-environmental factors deeply influence the performance of the Lutetium-177 Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Lutetium-177 Market

The Lutetium-177 Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Lutetium-177 Market

The Lutetium-177 Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Lutetium-177 Market

The Lutetium-177 Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lutetium-177 Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Bayer AG, BWX Technologies, Inc., Cardinal Health, Inc., Curium Pharma, Eckert & Ziegler Radiopharma GmbH, Framatome, Fusion Pharmaceuticals Inc. by AstraZeneca, IBA Radiopharma Solutions, Isotopia Ltd., ITM Isotope Technologies Munich SE, Lantheus Holdings, Inc., NorthStar Medical Radioisotopes, LLC, Novartis AG, NTP Radioisotopes SOC Ltd., Nuclear Research and Consultancy Group, PerkinElmer, Inc., RadioMedix, Inc., RayzeBio, Inc. by Bristol Myers Squibb, SHINE Technologies, LLC, and Telix Pharmaceuticals Limited.

Market Segmentation & Coverage

This research report categorizes the Lutetium-177 Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Application
    • Cancer Treatment
      • Neuroendocrine Tumors
      • Prostate Cancer
    • Palliative Care
      • Pain Management
      • Symptom Control
    • Radiopharmaceutical Therapy
      • Beta Therapy
      • Targeted Alpha Therapy
  • Type
    • Carrier-Added Lutetium-177
      • Enriched Carrier-Added
      • Standard Carrier-Added
    • No-Carrier-Added Lutetium-177
      • Advanced Purity
      • High Specific Activity
  • End User
    • Hospitals
      • Private Hospitals
      • Public Hospitals
    • Research Laboratories
      • Academic Institutions
      • Corporate Labs
    • Specialty Clinics
      • Oncology Clinics
      • Radiology Clinics
  • Production
    • Cyclotron-Based Production
      • Large Cyclotrons
      • Small Cyclotrons
    • Reactor-Based Production
      • Nuclear Reactors
      • Research Reactors
  • Delivery Form
    • Liquid Form
      • Ampoules
      • Vials
    • Mixed with Carrier
      • Microspheres
      • Peptide Bonding
  • Developing Technologies
    • Innovative Radio-Conjugate Techniques
      • Nanotechnology-Based Delivery
      • Viral Vector Methods
    • New Isotope Production
      • Isotope Enrichment
      • Target Design
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States (California, Florida, Illinois, New York, Ohio, Pennsylvania, Texas)
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  • Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  • Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  • Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  • Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  • Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  • What is the current size of the market, and how is it expected to grow?
  • Which products, segments, and regions present the most attractive investment opportunities?
  • What are the prevailing technology trends and regulatory factors influencing the market?
  • How do top vendors rank regarding market share and competitive positioning?
  • What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cancer globally spurs demand for innovative radiopharmaceutical treatments
5.1.1.2. Increasing investment in research and development accelerates new applications for lutetium-177
5.1.1.3. Growing awareness among healthcare professionals regarding the benefits of lutetium-177 therapies
5.1.2. Restraints
5.1.2.1. Potential competition from alternative radionuclides and treatments reducing market share for lutetium-177
5.1.2.2. Environmental and waste disposal challenges associated with the production of lutetium-177
5.1.2.3. Challenges in ensuring stringent quality control standards for lutetium-177 radiopharmaceuticals
5.1.3. Opportunities
5.1.3.1. Identifying unmet needs in Lutetium-177-based treatments during research and development phases
5.1.3.2. Analyzing the rise of Lutetium-177 isotopes in global nuclear medicine markets
5.1.3.3. Evaluating strategic partnerships and collaborations in Lutetium-177 supply chains globally
5.1.4. Challenges
5.1.4.1. Competition from existing and emerging radionuclide therapies posing a threat to Lutetium-177 market share
5.1.4.2. Addressing the cost constraints linked to the production and distribution of Lutetium-177 therapies
5.1.4.3. Market education and awareness issues impacting the prescription levels of Lutetium-177 treatments by professionals
5.2. Market Segmentation Analysis
5.2.1. Form: Proliferating usage of the non-carrier-added lutetium-177 minimizing side effects due to its high purity
5.2.2. Application: Burgeoning utilization of lutetium-177 in cancer treatment provides more focused therapeutic impact
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Lutetium-177 Market, by Application
6.1. Introduction
6.2. Cancer Treatment
6.2.1. Neuroendocrine Tumors
6.2.2. Prostate Cancer
6.3. Palliative Care
6.3.1. Pain Management
6.3.2. Symptom Control
6.4. Radiopharmaceutical Therapy
6.4.1. Beta Therapy
6.4.2. Targeted Alpha Therapy
7. Lutetium-177 Market, by Type
7.1. Introduction
7.2. Carrier-Added Lutetium-177
7.2.1. Enriched Carrier-Added
7.2.2. Standard Carrier-Added
7.3. No-Carrier-Added Lutetium-177
7.3.1. Advanced Purity
7.3.2. High Specific Activity
8. Lutetium-177 Market, by End User
8.1. Introduction
8.2. Hospitals
8.2.1. Private Hospitals
8.2.2. Public Hospitals
8.3. Research Laboratories
8.3.1. Academic Institutions
8.3.2. Corporate Labs
8.4. Specialty Clinics
8.4.1. Oncology Clinics
8.4.2. Radiology Clinics
9. Lutetium-177 Market, by Production
9.1. Introduction
9.2. Cyclotron-Based Production
9.2.1. Large Cyclotrons
9.2.2. Small Cyclotrons
9.3. Reactor-Based Production
9.3.1. Nuclear Reactors
9.3.2. Research Reactors
10. Lutetium-177 Market, by Delivery Form
10.1. Introduction
10.2. Liquid Form
10.2.1. Ampoules
10.2.2. Vials
10.3. Mixed with Carrier
10.3.1. Microspheres
10.3.2. Peptide Bonding
11. Lutetium-177 Market, by Developing Technologies
11.1. Introduction
11.2. Innovative Radio-Conjugate Techniques
11.2.1. Nanotechnology-Based Delivery
11.2.2. Viral Vector Methods
11.3. New Isotope Production
11.3.1. Isotope Enrichment
11.3.2. Target Design
12. Americas Lutetium-177 Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Lutetium-177 Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Lutetium-177 Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. SHINE Technologies partners with Blue Earth Therapeutics for prostate cancer
15.3.2. Nuclearelectrica and Framatome partnered to produce Lutetium-177 for targeted cancer treatments,
15.3.3. Nucleus Radiopharma and SHINE Technologies deal for high-purity Lutetium-177 to boost cancer treatment
15.3.4. SHINE Technologies opens Lu-177 production facility in North America, significantly boosting capacity for cancer treatments
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. LUTETIUM-177 MARKET MULTI-CURRENCY
FIGURE 2. LUTETIUM-177 MARKET MULTI-LANGUAGE
FIGURE 3. LUTETIUM-177 MARKET RESEARCH PROCESS
FIGURE 4. LUTETIUM-177 MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL LUTETIUM-177 MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL LUTETIUM-177 MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL LUTETIUM-177 MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL LUTETIUM-177 MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL LUTETIUM-177 MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL LUTETIUM-177 MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2023 VS 2030 (%)
FIGURE 17. GLOBAL LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2023 VS 2030 (%)
FIGURE 19. GLOBAL LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES LUTETIUM-177 MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES LUTETIUM-177 MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. LUTETIUM-177 MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. LUTETIUM-177 MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. LUTETIUM-177 MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL LUTETIUM-177 MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LUTETIUM-177 MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. LUTETIUM-177 MARKET DYNAMICS
TABLE 7. GLOBAL LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LUTETIUM-177 MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LUTETIUM-177 MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LUTETIUM-177 MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LUTETIUM-177 MARKET SIZE, BY SYMPTOM CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LUTETIUM-177 MARKET SIZE, BY BETA THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LUTETIUM-177 MARKET SIZE, BY TARGETED ALPHA THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LUTETIUM-177 MARKET SIZE, BY ENRICHED CARRIER-ADDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LUTETIUM-177 MARKET SIZE, BY STANDARD CARRIER-ADDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LUTETIUM-177 MARKET SIZE, BY ADVANCED PURITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LUTETIUM-177 MARKET SIZE, BY HIGH SPECIFIC ACTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LUTETIUM-177 MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LUTETIUM-177 MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LUTETIUM-177 MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LUTETIUM-177 MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LUTETIUM-177 MARKET SIZE, BY CORPORATE LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL LUTETIUM-177 MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL LUTETIUM-177 MARKET SIZE, BY RADIOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL LUTETIUM-177 MARKET SIZE, BY LARGE CYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL LUTETIUM-177 MARKET SIZE, BY SMALL CYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL LUTETIUM-177 MARKET SIZE, BY NUCLEAR REACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH REACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL LUTETIUM-177 MARKET SIZE, BY AMPOULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL LUTETIUM-177 MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL LUTETIUM-177 MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL LUTETIUM-177 MARKET SIZE, BY PEPTIDE BONDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL LUTETIUM-177 MARKET SIZE, BY NANOTECHNOLOGY-BASED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL LUTETIUM-177 MARKET SIZE, BY VIRAL VECTOR METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL LUTETIUM-177 MARKET SIZE, BY ISOTOPE ENRICHMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL LUTETIUM-177 MARKET SIZE, BY TARGET DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 130. CANADA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. CANADA LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 132. CANADA LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 133. CANADA LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 134. CANADA LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. CANADA LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 136. CANADA LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 137. CANADA LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. CANADA LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 139. CANADA LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 140. CANADA LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 141. CANADA LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 142. CANADA LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 143. CANADA LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 144. CANADA LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 145. CANADA LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 146. CANADA LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 147. CANADA LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 148. CANADA LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 149. CANADA LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 150. MEXICO LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. MEXICO LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 152. MEXICO LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 153. MEXICO LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 154. MEXICO LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 156. MEXICO LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 157. MEXICO LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. MEXICO LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 162. MEXICO LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 163. MEXICO LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 164. MEXICO LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 165. MEXICO LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 166. MEXICO LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 167. MEXICO LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 168. MEXICO LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES LUTETIUM-177 MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 232. CHINA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. CHINA LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 234. CHINA LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 235. CHINA LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 236. CHINA LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. CHINA LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 238. CHINA LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 239. CHINA LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. CHINA LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. CHINA LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 242. CHINA LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 243. CHINA LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 244. CHINA LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 245. CHINA LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 246. CHINA LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 247. CHINA LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 248. CHINA LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 249. CHINA LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 250. CHINA LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 251. CHINA LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 252. INDIA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. INDIA LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 254. INDIA LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 255. INDIA LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 256. INDIA LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. INDIA LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 258. INDIA LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 259. INDIA LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. INDIA LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 261. INDIA LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 262. INDIA LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 263. INDIA LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 264. INDIA LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 265. INDIA LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 266. INDIA LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 267. INDIA LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 268. INDIA LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 269. INDIA LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 270. INDIA LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 271. INDIA LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 289. INDONESIA LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 290. INDONESIA LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 291. INDONESIA LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 292. JAPAN LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. JAPAN LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 294. JAPAN LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 295. JAPAN LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 296. JAPAN LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 297. JAPAN LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 298. JAPAN LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 299. JAPAN LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. JAPAN LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. JAPAN LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 302. JAPAN LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 303. JAPAN LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 304. JAPAN LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 305. JAPAN LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 306. JAPAN LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 307. JAPAN LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 308. JAPAN LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 309. JAPAN LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 310. JAPAN LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 311. JAPAN LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 317. MALAYSIA LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 318. MALAYSIA LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 319. MALAYSIA LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. MALAYSIA LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 321. MALAYSIA LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 322. MALAYSIA LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 323. MALAYSIA LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 324. MALAYSIA LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 325. MALAYSIA LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 326. MALAYSIA LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 327. MALAYSIA LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 328. MALAYSIA LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 329. MALAYSIA LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 330. MALAYSIA LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 331. MALAYSIA LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY PALLIATIVE CARE, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 341. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 342. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 343. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 344. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 345. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
TABLE 346. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 347. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 348. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY MIXED WITH CARRIER, 2018-2030 (USD MILLION)
TABLE 349. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY DEVELOPING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 350. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY INNOVATIVE RADIO-CONJUGATE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 351. PHILIPPINES LUTETIUM-177 MARKET SIZE, BY NEW ISOTOPE PRODUCTION, 2018-20

Companies Mentioned

  • Actinium Pharmaceuticals, Inc.
  • Bayer AG
  • BWX Technologies, Inc.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler Radiopharma GmbH
  • Framatome
  • Fusion Pharmaceuticals Inc. by AstraZeneca
  • IBA Radiopharma Solutions
  • Isotopia Ltd.
  • ITM Isotope Technologies Munich SE
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • Novartis AG
  • NTP Radioisotopes SOC Ltd.
  • Nuclear Research and Consultancy Group
  • PerkinElmer, Inc.
  • RadioMedix, Inc.
  • RayzeBio, Inc. by Bristol Myers Squibb
  • SHINE Technologies, LLC
  • Telix Pharmaceuticals Limited.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 202.56 million
Forecasted Market Value ( USD ) by 2030 $ 653.53 million
Compound Annual Growth Rate21.4%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Radioligand Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Radioligand Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Lutetium-177 (CAS 14265-75-9) Global Market Research Report 2024 - Product Image

Lutetium-177 (CAS 14265-75-9) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
PSMA - Targeted Therapy Pipeline Review - Product Image

PSMA - Targeted Therapy Pipeline Review

  • Report
  • Global
From
Cancer Supportive Care Products Market Report 2024 - Product Image

Cancer Supportive Care Products Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 306 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.